These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19660856)

  • 21. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer.
    Dindyal S; Nitkunan T; Bunce CJ
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):153-8. PubMed ID: 19356647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photodynamic diagnostics of bladder carcinoma].
    Vom Dorp F; Tschirdewahn S; Olbricht T; Szarvas T; Rübben H
    Urologe A; 2011 Sep; 50(9):1068-71. PubMed ID: 21845422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value and limitations of urinary cytology in the diagnosis of bladder tumors].
    Raica M; Ioan I
    Acta Urol Belg; 1991; 59(4):133-47. PubMed ID: 1726382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.
    Grimbergen MC; van Swol CF; Jonges TG; Boon TA; van Moorselaar RJ
    Eur Urol; 2003 Jul; 44(1):51-6. PubMed ID: 12814675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.
    Jain S; Kockelbergh RC
    BJU Int; 2005 Jul; 96(1):17-21. PubMed ID: 15963113
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fluorescent diagnostics of urinary bladder cancer].
    Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
    Urologiia; 2000; (4):3-6. PubMed ID: 11186690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? Yes.
    Witjes JA
    J Urol; 2013 Jul; 190(1):19-20. PubMed ID: 23603096
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytologic diagnosis of transitional cell carcinoma of the urinary bladder. Comparison with endoscopical and pathological findings on 538 cases.
    Raica M; Minciu R; Miclea F; Botoca M; Drăgan P; Ioiart I
    Rom J Morphol Embryol; 1997; 43(3-4):155-61. PubMed ID: 9747115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model.
    Wang ZG; Durand DB; Schoenberg M; Pan YT
    J Urol; 2005 Dec; 174(6):2376-81. PubMed ID: 16280851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
    Witjes JA; Redorta JP; Jacqmin D; Sofras F; Malmström PU; Riedl C; Jocham D; Conti G; Montorsi F; Arentsen HC; Zaak D; Mostafid AH; Babjuk M
    Eur Urol; 2010 Apr; 57(4):607-14. PubMed ID: 20116164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases.
    Swick BL; Gordon JR
    J Cutan Pathol; 2010 Dec; 37(12):1245-50. PubMed ID: 19919656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
    Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
    Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
    Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
    Urologiia; 2000; (3):22-4. PubMed ID: 11186703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluorescence diagnosis and photodynamic therapy in urology].
    Stepp H; Waidelich R
    Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
    Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
    Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder carcinoma: MDCT cystography and virtual cystoscopy.
    Panebianco V; Sciarra A; Di Martino M; Bernardo S; Vergari V; Gentilucci A; Catalano C; Passariello R
    Abdom Imaging; 2010 Jun; 35(3):257-64. PubMed ID: 19471998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.